CASE REPORT | https://doi.org/10.5005/jp-journals-10005-1999 |
Novel Treatment Approach of Oral Submucous Fibrosis in a 6-year-old Girl: A Case Report
1–6Department of Oral Medicine and Radiology, Maulana Azad Institute of Dental Sciences, New Delhi, India
Corresponding Author: Shikha Gupta, Department of Oral Medicine and Radiology, Maulana Azad Institute of Dental Sciences, New Delhi, India, Phone: +91 9910419028, e-mail: calmshikhs@yahoo.com
How to cite this article Gupta S, Gupta S, Chaudhary C, et al. Novel Treatment Approach of Oral Submucous Fibrosis in a 6-year-old Girl: A Case Report. Int J Clin Pediatr Dent 2021;14(4):575–579.
Source of support: Nil
Conflict of interest: None
ABSTRACT
Background: Oral submucous fibrosis is characterized by stiffness of oral mucosa, blanching and functional limitation, and areca nut predisposition is considered to be one of the main etiological factors. In recent years, there is an increasing prevalence of OSMF in the Indian subcontinent owing to increased consumption of smokeless tobacco products. Very few cases of pediatric OSMF are reported in PubMed literature. Oral submucous fibrosis has a malignant transformation rate of 7–13% and hence, it is important to intervene at an appropriate stage and manage it well in time.
Aim and objective: To report a case of oral submucous fibrosis (OSMF) in a 6-year-old Indian girl along with its management and follow-up.
Case description: A 6-year-old girl of Indian origin was diagnosed with OSMF and we have used sesame oil pulling as a novel treatment approach and observed good results with long-term follow-up. We have also reviewed PubMed literature for cases of pediatric OSMF reported till date.
Conclusion: A timely diagnosis and intervention becomes necessary in pediatric OSMF to improve oral function and prevent malignant transformation.
Clinical significance: It is important to report oral potentially malignant disorder (OPMD) cases in pediatric patients and create awareness through health education programs so that parents and children know about the ill effects of consuming tobacco products.
Keywords: Areca nut, Oral Fibrosis, Oral submucous fibrosis, Pediatric.
INTRODUCTION
Oral submucous fibrosis (OSMF) is an oral potentially malignant disorder (OPMD) described by Schwartz in 1952 as “Atrophica idiopathica mucosae oris” and by Pindborg as “a chronic, insidious, scarring disease of the oral cavity, often with involvement of the pharynx and the upper esophagus”.1 The use of smokeless tobacco in various forms is very popular in the Indian subcontinent and areca nut chewing is considered as the main risk factor for OSMF.2 It is characterized by reduced movement and depapillation of the tongue, blanching and leathery texture of mucosa, trismus, and inability to eat, associated with the formation of vesicle due to juxtaepithelial inflammatory reaction followed by fibroelastic changes in lamina propria and epithelial atrophy.3 The prevalence of OSMF in the Indian subcontinent has been estimated to range from 0.2 to 2.3% in males and 1.2 to 4.6% in females, with a broad age range from 11 to 60 years.4 In recent years, there is an increased prevalence of OSMF in the younger population mainly due to household environment, peer pressure, and attractive pouches of areca nut products. Oral submucous fibrosis has a high malignant transformation rate of 7 to 13% and therefore, its early diagnosis and treatment becomes crucial in pediatric patients.5 To date, there is no definitive treatment modality and is mainly aimed at symptomatic relief and prevention of its progression to oral cancer. Very few cases of pediatric OSMF have been reported in the literature.
Therefore, we present here a case of OSMF in a young Indian girl of 6 years along with treatment and follow-up. This is the first case of pediatric OSMF wherein sesame oil pulling has been used as a treatment modality and significant improvement evident.
CASE DESCRIPTION
Case History and Presentation
A girl aged 6 years reported with her mother to the Department of Oral Medicine and Radiology of a Tertiary Care Dental Hospital with the chief complaint of inability to open mouth along with a burning sensation of mucosa while taking spicy food for 6 months. The medical history was non-contributory. The patient reported a habit of chewing areca nut 3 to 4 times a day for the past 4 years. A long-standing history of chewing areca nut was present in her grandmother who infused this habit in her granddaughter not knowing the harmful effects of the same. General physical examination was non-contributory. Extraoral examination revealed a restricted mouth opening of 9 mm. Intraoral examination revealed blanching of upper and lower labial mucosa, bilateral buccal mucosa, and palate. There was depapillation of the anterior dorsal surface of the tongue (Fig. 1). The tongue movements were restricted and tongue protrusion was 28.52 mm. Vertically thick fibrous bands were palpable on bilateral buccal mucosa, pterygomandibular raphe, hard and soft palate. Positive history of chewing areca nut along with clinical findings led to a provisional diagnosis of OSMF.
Diagnosis
An incisional biopsy was performed from the right buccal mucosa and histopathological examination showed parakeratinized stratified squamous epithelium with a short blunt to flattened rete ridges with stromal tissue composed of densely bundled collagen fibers, and juxtaepithelial hyalinization (Fig. 2). The overall picture was suggestive of highly advanced OSMF.
Figs 1A to C: Blanching on the right buccal mucosa, left buccal mucosa and palate, and depapillation of anterior dorsal surface of tongue
Fig. 2: Microphotograph of patient suggestive of oral submucous fibrosis (10× HandE)
Figs 3A and B: Pre- and posttreatment values of mouth opening
Figs 4A and B: Pre- and posttreatment values of tongue protrusion
Management and Follow-up
The patient and her mother were counseled regarding the adverse effects of chewing areca nut and the potential to cause oral cancer. The patient was advised to stop chewing areca nut. She was treated with sesame oil pulling for 5 minutes daily along with topical application of triamcinolone acetonide (0.1%) and curcumin tablet 300 mg once daily. The patient was given a sesame oil sachet and was instructed to perform oil pulling every day on an empty stomach by emptying the entire 10 mL of oil and swishing it in the mouth for at least 5 minutes without swallowing the oil. This was followed by spitting the oil and brushing the teeth. The patient was refrained from eating anything for at least 30 minutes. The patient was followed up at a regular interval of 1 month up to 6 months followed by follow-up at an interval of 3 months thereafter. She has stopped chewing areca nuts and showed improvement in symptoms. After 3 years of follow-up, the mouth opening is 22.29 mm (Fig. 3) and tongue protrusion is 33.39 mm (Fig. 4). Patient is still under follow-up.
DISCUSSION
Oral submucous fibrosis is a chronic disease associated with functional limitation and potential for malignant transformation. In recent years, areca nut chewing is thought to be the main etiological factor involved in the pathogenesis of OSMF. Various other factors implicated in its etiopathogenesis are nutritional deficiency, consumption of chilies, genetic predisposition, and immunological process.6,7 Arecoline, arecaidine, guvacoline, and guacine are the main alkaloids in the areca nut with arecoline being the most abundant that causes collagen synthesis and fibrosis.6,8 There is an increasing prevalence of OSMF in the Indian subcontinent mainly due to the increased habit of smokeless tobacco consumption among younger generations. From Table 1, it can be seen that majority of children had a habit of chewing areca nut.1,2,9,11–13 In the present case series also, the patient had a habit of consuming areca nut. Areca nut has a sweet flavor and because of its mouth freshening action, it is consumed by the children in larger amounts and for longer periods of time.13,15 Various factors are involved in increasing the consumption of tobacco products among children. Family environment, cultural habits, low awareness, easy availability, low cost, peer pressure, etc., play a major role.12,13
| S.no. | Author and year | No. of cases | Age | Sex | Habit | Mouth opening | Ethnicity | Treatment |
|---|---|---|---|---|---|---|---|---|
| 1 | Hayes et al.1 1985 | 1 | 4 | F | Areca nut | 11 mm | Indian | Vitamin supplements, stretching exercises |
| 2 | Anil et al.9 1993 | 1 | 12 | F | Areca nut | 15 mm | Indian | Submucosal placental extract |
| 3 | Mundra et al.10 1999 | 1 | 8 | F | Betel nut | 20 mm | Indian | Conservative treatment |
| 4 | Yusuf et al.2 2002 | 1 | 12 | M | Areca nut | 21 mm | Bangladesh | Mouth opening exercises + conservative treatment |
| 5 | Agrawal et al.11 2002 | 1 | 9 | F | Areca nut | 16 mm | Indian | Intralesional Injection of placental extracts alone, a combination of dexamethasone and hyaluronidase weekly for 8 weeks |
| 6 | Dhariwal et al.5 2012 | 2 | 10 | M | Gutkha | 15 mm | Indian | Oral iron supplements, vitamin A, and zinc acetate |
| 12 | F | Paan masala | 19 mm | Indian | Oral vitamin A and zinc acetate syrup | |||
| 7 | Deshpande et al.6 2013 | 1 | 14 | F | Areca nut and tobacco | 30 mm | Indian | Oral vitamin B complex, vitamin A, E, and C |
| 8 | Gupta et al.12 2013 | 2 | 11 | F | Areca nut | 14 mm | Indian | Mouth opening exercises |
| 10 | M | Areca nut | 13 mm | Indian | Not reported | |||
| 9 | Duggirala et al.13 2015 | 3 | 9 | F | Areca nut | 14 mm | Indian | Oral vitamin A, vitamin E for 3 months, and ferrous fumarate tablets for 1 month |
| 13 | M | Paan | 22 mm | Indian | Oral vitamin A, vitamin E, and zinc acetate syrup for 3 months + intralesional injection of corticosteroid for 2 months | |||
| 10 | Talla et al.14 2019 | 1 | 5 | F | Betel nut | 15 mm | Indian | Topical steroid, multivitamin syrup, diluted tulsi water, physiotherapy |
M: Male, F: Female
There are around 14 cases of OSMF in children in PubMed literature as shown in Table 1. The age group ranged from 4 to 14 years with the first case being reported by Hayes et al. in 1985.1 In recent years, there appears to be a predisposition of OSMF in adult females. However, no sex predilection is reported in children but some studies have reported areca nut consumption to be more common among males.16,17 In the review of literature, it can be seen that the majority of children are females with only four males. All except one patient in Table 1 are of Indian origin, thereby implying that OSMF in a pediatric age group is more common in the Indian subcontinent.
Diagnosis can be done on basis of clinical signs and symptoms such as burning sensation on consuming spicy foods, blanching and stiffening of the mucosa, with reduced oral functions such as swallowing, reduced mouth opening, and sometimes accompanied by vesicle formation. A characteristic feature is the formation of fibrous palpable bands on the buccal mucosa, labial mucosa, and soft palate.13,18 The association of OSMF with the development of oral cancer highlights the importance of patient counseling and education as the first step in its management. With the increasing number of OSMF cases in the pediatric population, it is essential to educate the parents and children about the ill effects of consuming tobacco. This can be done through educational campaigns, schools, newspapers, multimedia, and enforcing legislation to ban the sale of tobacco products to young children.
The goal of the treatment in OSMF is an alleviation of symptoms, improved oral functioning, and prevention of malignant transformation. Treatment ranging from the cessation of habit, medical, and non-medical interventions has been employed for the management of OSMF but so far, a definitive treatment modality has not been able to completely cure the disease and a combination of treatment strategies is used. Cessation of habit forms the most vital step in management. Among medical interventions, micronutrient supplements such as vitamin A, B complex, C and E, copper and zinc supplements, and iron have been used alone or in combination and the trials have shown good results with marked improvement.19–22 Antioxidants such as lycopene, beta-carotene, curcumin, spirulina, and aloe vera have been tried with the rationale that these scavenge free radicals, and reactive oxygen species generated due to areca nut.23 Lycopene has been used for the management of other OPMDs as well and in OSMF, trials have shown improvement in burning sensation and mouth opening.24,25 Curcumin is also being investigated for its role in preventing fibrosis by decreasing the levels of type I and III collagen in OSMF and has shown good results.26 Steroid has been used as topical therapy such as betamethasone and triamcinolone or as intralesional injection of dexamethasone in combination with hyaluronidase.27,28 It is believed that steroids reduce inflammation in OSMF. Various other therapies that have been used include placental extracts, interferon-gamma, pentoxifylline, and isoxsuprine.22 Surgical interventions are reserved for cases that do not respond to conservative treatment and in advanced cases of OSMF.
Literature on the role of sesame oil pulling and oral health is limited. Patel et al. have used sesame oil pulling for the management of OSMF along with other Ayurveda therapies.29 They found statistically significant improvement in mouth opening, burning sensation, blanching, and ulceration of the mucosa. Sesame oil according to Ayurveda has the properties of healing, anti-inflammatory, and strength enhancing and along with the technique of oil pulling; it works as a physiotherapeutic measure to improve stiffness.29 Oil pulling involves sipping, sucking, and swishing the oil in the mouth for 10–15 minutes and is preferably done on an empty stomach.
In the present case, we have employed sesame oil pulling and curcumin for management and we have seen a marked improvement in mouth opening, tongue protrusion, and burning sensation. It was well tolerated by the patient with no side effects. To the best of our knowledge, this is the first case of pediatric OSMF with sesame oil pulling as the management strategy.
CONCLUSION
A timely diagnosis and intervention becomes necessary in pediatric OSMF to improve oral function and prevent malignant transformation.
It is important to report OSMF cases in pediatric patients and create awareness through health education programs so that parents and children know about the ill effects of consuming tobacco products. Sesame oil pulling and curcumin can be used for the management of OSMF as it shows promising results and has no side effects.
REFERENCES
1. Hayes PA. Oral submucous fibrosis in a 4-year-old girl. Oral Surg Oral Med Oral Pathol 1985;59(5):475–478. DOI: 10.1016/0030-4220(85)90087-8.
2. Yusuf H, Yong SL. Oral submucous fibrosis in a 12-year-old Bangladeshi boy: a case report and review of literature. Int J Paediatr Dent 2002;12(4):271–276. DOI: 10.1046/j.1365-263x.2002.00373.x.
3. Kariya P, Khobragade V. No age predilection for a disease like OSMF. A case report of 5-year-old child. J Oral Biol Craniofac Res 2020;10(2):153–157. DOI: 10.1016/j.jobcr.2020.03.010.
4. Rao NR, Villa A, More CB. Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. J Otolaryngol Head Neck Surg 2020;49(1):3. DOI: 10.1186/s40463-020-0399-7.
5. Dhariwal R, Ray JG. Oral submucous eibrosis: a report of two paediatric cases and a brief review. J Ind Soc Pedod Prev Dent 2012;30(1):85–88. DOI: 10.4103/0970-4388.95592.
6. Deshpande A, Kiran S, Dhillon S, et al. Oral submucous fibrosis: a premalignant condition in a 14 year old Indian girl. BMJ Case Rep 2013 (dec12 1). DOI: 10.1136/bcr-2013-200786.
7. Karemore TV, Karemore VA. Etiopathogenesis and treatment strategies of oral submucous fibrosis. J Indian Acad Oral Med Radiol 2011;23:598–602. DOI: 10.5005/jp-journals-10011-1230.
8. Rajlalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis: a collagen metabolic disorder. J Oral Pathol Med 2005;34(6):321–328. DOI: 10.1111/j.1600-0714.2005.00325.x.
9. Anil S, Beena VT. Oral submucous fibrosis in a 12-year-old girl: case report. Pediatr Dent 1993;15(2):120–122.
10. Mundra RK, Gupta SK, Gupta Y. Oral submucous fibrosis in paediatric age group. IJO HNS 1999;51(3):60–62. DOI: 10.1007/BF02996533.
11. Agrawal A, Sarkar AP, Shigli A. Oral submucous fibrosis in a 9-year old Indian girl. BMJ Case Rep 2011;2011 (sep28 1):bcr0820114588. DOI: 10.1136/bcr.08.2011.4588.
12. Gupta VK, Malhotra S, Patil R, et al. Oral submucous fibrosis at pediatric age, now time to think: Series of two cases. Indian J Med Paediatr Oncol 2013;34(2):107–110. DOI: 10.4103/0971-5851.116194.
13. Duggirala TL, Marthala M, Gannepalli A, et al. Oral submucous fibrosis in children: Report of three cases and review. J Ind Acad Oral Med Radiol 2015;27(1):105–111. DOI: 10.4103/0972-1363.167127.
14. Talla H, Reddy PVR, Mudavath M, et al. Oral submucous fibrosis in a 5 year old child. Contemp Clin Dent 2019;14(4):679–681. DOI: 10.4103/ccd.ccd_898_18.
15. Garg A, Chaturvedi P, Gupta PC. A review of the systemic adverse effects of areca nut or betel nut. Indian J Med Paediatr Oncol 2014;35(1):3–9. DOI: 10.4103/0971-5851.133702.
16. Joseph N, Nagaraj K, Shashidhar Kotian M. Arecanut and tobacco use among school children in a village in South India – A cross-sectional study. AMJ 2010;3:299–303. DOI: 10.4066/AMJ.2010.280.
17. Khandelwal A, Khandelwal V, Saha MK, et al. Prevalence of areca nut chewing in the middle school-going children of Indore, India. Contemp Clin Dent 2012;3(2):155–157. DOI: 10.4103/0976-237X.96817.
18. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966;22(6):764–779. DOI: 10.1016/0030-4220(66)90367-7.
19. Gupta PC, Hebert JR, Bhonsle RB, et al. Dietary factors in oral leukoplakia and submucous fibrosis in a population-based case control study in Gujarat, India. Oral Dis 1998;4(3):200–206. DOI: 10.1111/j.1601-0825.1998.tb00279.x.
20. Kumar N, Sharma SC, Sharma P, et al. Beneficial effect of oral zinc in the treatment of oral submucous fibrosis. Indian J Pharmacol 1991;23:236–241.
21. Tilakaratne WM, Ekanayaka RP, Warnakulasuriya S. Oral submucous fibrosis: a historical perspective and a review on aetiology and pathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol 2015.(in Press).
22. Warnakulasuriya S, Kerr AR. Oral submucous fibrosis: a review of the current management and possible directions for novel therapies. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122(2):232–241. DOI: 10.1016/j.oooo.2016.02.020.
23. Nair U, Bartsch H, Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 2004;19(4):251–262. DOI: 10.1093/mutage/geh036.
24. Singh M, Krishanappa R, Bagewadi A, et al. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncol 2004;40(6):591–596. DOI: 10.1016/j.oraloncology.2003.12.011.
25. Saawarn N, Shashikanth MC, Saawarn S, et al. Lycopene in the management of oral lichen planus: a placebo-controlled study. Indian J Dent Res 2011;22(5):639–643. DOI: 10.4103/0970-9290.93448.
26. Gupta S, Ghosh S, Gupta S, et al. Effect of curcumin on the expression if p53, transforming growth factor, and inducible nitric oxide synthase in oral submucous fibrosis: a pilot study. J Invest Clin Dent 2016. 1–6.
27. Borle RM, Borle SR. Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 1991;49(8):788–791. DOI: 10.1016/0278-2391(91)90002-4.
28. Lai DR, Chen HR, Lin LM, et al. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med 1995;24(9):402–406. DOI: 10.1111/j.1600-0714.1995.tb01209.x.
29. Patel KR, Rajagopala M, Vaghela DB, et al. A pilot study on ayurvedic management of oral submucous fibrosis. Ayu 2015;36(1):34–40. DOI: 10.4103/0974-8520.169018.
________________________
© The Author(s). 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.